Description

Femara (letrozole) Coated Tablets 2.5 mg. №30

Ingredients:

Each coated tablet contains 2.5 mg of letrozole as the active ingredient.

Dosage:

The recommended dose is one 2.5 mg tablet taken once daily.

Indications:

Femara (letrozole) is indicated for the treatment of hormone receptor-positive breast cancer in postmenopausal women.

Contraindications:

Do not use Femara if you are pregnant, as it may cause harm to the unborn baby.

Directions:

Take Femara exactly as prescribed by your doctor. Do not take more or less than the recommended dose.

Scientific Evidence:

Femara (letrozole) has been extensively studied in clinical trials for its efficacy in the treatment of breast cancer. Research has shown that letrozole is a potent aromatase inhibitor, effectively reducing estrogen levels in postmenopausal women with hormone receptor-positive breast cancer.

Additional Information:

It is important to discuss any existing medical conditions and medications with your healthcare provider before starting Femara treatment. Common side effects may include hot flashes, fatigue, and joint pain. Contact your doctor if you experience any severe or persistent side effects.

Studies have also compared the effectiveness of Femara with other aromatase inhibitors in the adjuvant treatment of breast cancer. Results have shown that Femara may offer improved outcomes in terms of disease-free survival and overall survival rates.